InvestorsHub Logo
Followers 833
Posts 119841
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 19365

Wednesday, 11/06/2019 9:17:22 AM

Wednesday, November 06, 2019 9:17:22 AM

Post# of 29399
ELAN 3Q19 results:

https://investor.elanco.com/investors/press-releases/press-release-details/2019/Elanco-Animal-Health-Reports-Third-Quarter-Results/default.aspx

The upper bound of the 2019-guidance range for non-GAAP EPS was lowered slightly; the new non-GAAP EPS range is $1.04-1.08 (vs the prior range of $1.04-1.10).

3Q19 results and forward guidance do not include Bayer’s animal health business, which ELAN is in the process of acquiring (#msg-150629685).

The stock is -4% in PM trading.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.